How to Address Stability Issues in ANDA Submissions to the US FDA
How to Address Stability Issues in ANDA Submissions to the US FDA Handling Stability Challenges in ANDA Submissions to the FDA Introduction Abbreviated New Drug Application (ANDA) submissions to the US FDA require comprehensive stability data to demonstrate that a generic drug product meets the same quality, safety, and efficacy standards as its reference listed…
Read More “How to Address Stability Issues in ANDA Submissions to the US FDA” »